Mark Bloomston

1.3k total citations
36 papers, 948 citations indexed

About

Mark Bloomston is a scholar working on Oncology, Surgery and Epidemiology. According to data from OpenAlex, Mark Bloomston has authored 36 papers receiving a total of 948 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 13 papers in Surgery and 13 papers in Epidemiology. Recurrent topics in Mark Bloomston's work include Pancreatic and Hepatic Oncology Research (11 papers), Neuroendocrine Tumor Research Advances (10 papers) and Hepatocellular Carcinoma Treatment and Prognosis (8 papers). Mark Bloomston is often cited by papers focused on Pancreatic and Hepatic Oncology Research (11 papers), Neuroendocrine Tumor Research Advances (10 papers) and Hepatocellular Carcinoma Treatment and Prognosis (8 papers). Mark Bloomston collaborates with scholars based in United States, Switzerland and Italy. Mark Bloomston's co-authors include Sherif Abdel‐Misih, Wendy L. Frankel, Kara Keplinger, E. Christopher Ellison, Carl Schmidt, Tanios Bekaii‐Saab, Manisha H. Shah, Carlos Muro‐Cacho, Jeff X. Zhou and Alexander S. Rosemurgy and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.

In The Last Decade

Mark Bloomston

36 papers receiving 934 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Bloomston United States 18 351 293 201 200 163 36 948
Hao Yu China 22 294 0.8× 396 1.4× 305 1.5× 316 1.6× 126 0.8× 87 1.8k
Zhenhua Hu China 17 374 1.1× 278 0.9× 263 1.3× 252 1.3× 247 1.5× 64 1.0k
Kazuhiro Koikawa Japan 10 438 1.2× 505 1.7× 207 1.0× 238 1.2× 169 1.0× 15 1.2k
Jie Deng China 21 496 1.4× 104 0.4× 222 1.1× 259 1.3× 157 1.0× 77 1.5k
Florian Bösch Germany 16 412 1.2× 263 0.9× 233 1.2× 213 1.1× 68 0.4× 49 1.0k
Katja Evert Germany 19 177 0.5× 161 0.5× 155 0.8× 433 2.2× 86 0.5× 79 1.3k
Divya Dahiya India 17 271 0.8× 449 1.5× 145 0.7× 226 1.1× 155 1.0× 130 1.1k
Isabella Reccia United Kingdom 18 147 0.4× 503 1.7× 207 1.0× 265 1.3× 138 0.8× 48 1.1k
Akira Nakano Japan 19 262 0.7× 508 1.7× 101 0.5× 205 1.0× 68 0.4× 130 1.4k
Funda Yılmaz Türkiye 20 226 0.6× 426 1.5× 393 2.0× 262 1.3× 337 2.1× 83 1.2k

Countries citing papers authored by Mark Bloomston

Since Specialization
Citations

This map shows the geographic impact of Mark Bloomston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Bloomston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Bloomston more than expected).

Fields of papers citing papers by Mark Bloomston

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Bloomston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Bloomston. The network helps show where Mark Bloomston may publish in the future.

Co-authorship network of co-authors of Mark Bloomston

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Bloomston. A scholar is included among the top collaborators of Mark Bloomston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Bloomston. Mark Bloomston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chakedis, Jeffery, Eliza W. Beal, Steven Sun, et al.. (2018). Implementation and early outcomes for a surgeon‐directed hepatic arterial infusion pump program for colorectal liver metastases. Journal of Surgical Oncology. 118(7). 1065–1073. 10 indexed citations
2.
Mace, Thomas A., Ming Jin, Ching‐Shih Chen, et al.. (2017). Inhibition of Jak/STAT signaling reduces the activation of pancreatic stellate cells in vitro and limits caerulein-induced chronic pancreatitis in vivo. Scientific Reports. 7(1). 1787–1787. 63 indexed citations
3.
Shirley, Lawrence A., Jon Walker, Somashekar G. Krishna, et al.. (2016). Routine Cyst Fluid Cytology Is Not Indicated in the Evaluation of Pancreatic Cystic Lesions. Journal of Gastrointestinal Surgery. 20(9). 1581–1585. 7 indexed citations
4.
Bloomston, Mark, et al.. (2016). Hepatic Artery Infusional Chemotherapy. Surgical Clinics of North America. 96(2). 341–355. 17 indexed citations
5.
Onesti, Jill K., Lawrence A. Shirley, Neil Saunders, et al.. (2015). Elevated Alkaline Phosphatase Prior to Transarterial Chemoembolization for Neuroendocrine Tumors Predicts Worse Outcomes. Journal of Gastrointestinal Surgery. 20(3). 580–586. 12 indexed citations
6.
Prakash, Shaurya, Charles L. Hitchcock, Sylvain Nichols, et al.. (2015). Ex vivoelectrical impedance measurements on excised hepatic tissue from human patients with metastatic colorectal cancer. Physiological Measurement. 36(2). 315–328. 47 indexed citations
7.
Kavecansky, Juraj, et al.. (2014). Bone Metastases in Well-to-Moderately Differentiated Neuroendocrine Tumors. Pancreas. 44(2). 198–203. 24 indexed citations
8.
Bloomston, Mark, Peter Muscarella, Somashekar G. Krishna, et al.. (2014). Comparative outcomes of patients with intraductal papillary mucinous neoplasm associated cancer (IPMN-Ca) to those with pancreatic ductal carcinoma (PDAC) following resection.. Journal of Clinical Oncology. 32(15_suppl). e15227–e15227. 1 indexed citations
9.
Albert, Scott P., Lawrence A. Shirley, Carl Schmidt, et al.. (2014). Outcomes in Patients with Obstructive Jaundice from Metastatic Colorectal Cancer and Implications for Management. Journal of Gastrointestinal Surgery. 18(12). 2186–2191. 9 indexed citations
10.
Jin, Linda X., Yan Yan, Malcolm H. Squires, et al.. (2014). The effect of postoperative morbidity on survival after resection for gastric adenocarcinoma: Results from the U.S. Gastric Cancer Collaborative.. Journal of Clinical Oncology. 32(3_suppl). 5–5. 13 indexed citations
11.
Henry, Jon C., Claudio Bassi, Francesco Giovinazzo, & Mark Bloomston. (2013). MicroRNA from Pancreatic Duct Aspirate Differentiates Cystic Lesions of the Pancreas. Annals of Surgical Oncology. 20(S3). 661–666. 13 indexed citations
12.
Jones, Natalie, Manisha H. Shah, & Mark Bloomston. (2012). Liver-Directed Therapies in Patients With Advanced Neuroendocrine Tumors. Journal of the National Comprehensive Cancer Network. 10(6). 765–774. 10 indexed citations
13.
Bellizzi, Andrew M., Mark Bloomston, Xiaoping Zhou, O. Hans Iwenofu, & Wendy L. Frankel. (2010). The mTOR Pathway is Frequently Activated in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis. Applied immunohistochemistry & molecular morphology. 18(5). 442–447. 31 indexed citations
14.
Quick, Allison, Mark Bloomston, Edward Y. Kim, Nathan C. Hall, & Nina A. Mayr. (2009). Complete response to radiation therapy of orbital metastasisfrom hepatocellular carcinoma. World Journal of Gastroenterology. 15(47). 6000–6000. 12 indexed citations
15.
Bekaii‐Saab, Tanios, et al.. (2008). Complete clinical response of metastatic hepatocellular carcinoma to sorafenib in a patient with hemochromatosis: A case report. Journal of Hematology & Oncology. 1(1). 18–18. 42 indexed citations
16.
Kim, Edward Y., et al.. (2008). Yttrium-90 microsphere induced gastrointestinal tract ulceration. World Journal of Surgical Oncology. 6(1). 93–93. 31 indexed citations
17.
Varker, Kimberly A., et al.. (2007). Repeat Transarterial Chemoembolization (TACE) for Progressive Hepatic Carcinoid Metastases Provides Results Similar to First TACE. Journal of Gastrointestinal Surgery. 11(12). 1680–1685. 23 indexed citations
18.
Bloomston, Mark, Fu‐Sheng Chou, Theodore S. Glickman, et al.. (2007). Rosiglitazone sensitizes MDA-MB-231 breast cancer cells to anti-tumour effects of tumour necrosis factor-α, CH11 and CYC202. Endocrine Related Cancer. 14(2). 305–315. 29 indexed citations
19.
Bloomston, Mark, E. Christopher Ellison, Peter Muscarella, et al.. (2006). Stromal Osteonectin Overexpression Is Associated with Poor Outcome in Patients with Ampullary Cancer. Annals of Surgical Oncology. 14(1). 211–217. 26 indexed citations
20.
Bloomston, Mark, Jeff X. Zhou, Alexander S. Rosemurgy, et al.. (2006). Fibrinogen γ Overexpression in Pancreatic Cancer Identified by Large-scale Proteomic Analysis of Serum Samples. Cancer Research. 66(5). 2592–2599. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026